10x Genomics, Inc.
TXG
$18.81
$0.060.32%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 23.16% | 191.14% | 42.69% | -0.16% | 61.55% |
| Total Depreciation and Amortization | 13.96% | -11.46% | -14.62% | -9.76% | -5.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20.76% | -29.44% | -21.55% | -27.96% | -16.06% |
| Change in Net Operating Assets | 144.54% | -1,220.76% | 549.10% | -108.06% | -19.65% |
| Cash from Operations | 99.69% | 136.23% | 318.45% | -126.20% | 185.52% |
| Capital Expenditure | 82.33% | 45.17% | 34.95% | 21.28% | 74.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 85.24% | -95.69% | -- | -395.36% | -98.65% |
| Cash from Investing | -143.26% | -107.86% | -117.80% | -493.89% | -173.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 295.51% | -23.48% | -74.24% | -19.53% | -96.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 295.51% | -23.48% | -74.24% | -19.53% | -96.43% |
| Foreign Exchange rate Adjustments | -121.15% | 12,100.00% | 337.50% | -449.35% | 283.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 90.88% | -14.11% | 1,041.88% | -221.43% | 213.78% |